2018
DOI: 10.1016/j.clineuro.2018.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: A review and update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
19
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 183 publications
0
19
0
Order By: Relevance
“…Hence, the intrathecal (ITH) or intraventricular (IVT) administration of antibiotics had been performed in recent years [34][35][36][37]. Whereas, ITH and IVT antibiotic therapy has not been standardized [2]. Further work is needed to explore the antimicrobial therapy through ITH/IVT approach, this might signi cantly improve the outcomes of patients with CNS infections.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hence, the intrathecal (ITH) or intraventricular (IVT) administration of antibiotics had been performed in recent years [34][35][36][37]. Whereas, ITH and IVT antibiotic therapy has not been standardized [2]. Further work is needed to explore the antimicrobial therapy through ITH/IVT approach, this might signi cantly improve the outcomes of patients with CNS infections.…”
Section: Discussionmentioning
confidence: 99%
“…Epidemiology, pathogens distribution, antibiotic susceptibility and the risk factors for mortality of patients with central nervous system infections: a retrospective study from 2012 to 2019 in a teaching hospital in China Background Central nervous system (CNS) infections include meningitis, encephalitis, and brain abscesses, can be complications following neurosurgical operations or occur spontaneously [1,2]. CNS infections cause signi cant mortality worldwide, resulting in a poor prognosis with prolonged length of hospital stay and increasing the total cost of illness [1][2][3][4][5]. The pathogens causing such infections include bacteria, viruses, fungi and parasites, and it is reported that there are more than 100 pathogens that cause CNS infections [5].…”
mentioning
confidence: 99%
“…The use of intrathecal/intraventricular antimicrobials in this setting has not been well studied. A review of the existing literature reveals no standard protocol for the administration of intraventricular antimicrobials in the setting of CNS infections [10]. The risk reward profile focuses on the advantages of higher doses of antimicrobials in the CSF than can cross the blood brain barrier alone versus the increased risk of toxicity.…”
Section: Discussionmentioning
confidence: 99%
“…Common pathogens include Klebsiella species, Pseudomonas species, Acinetobacter baumannii, and Escherichia coli. 33,34 Third-and fourth-generation cephalosporins are common first-line empiric agents, though carbapenems can be considered as well. 13 Resistant organisms may require the use of aminoglycosides, polymyxin B, or colistin via intravenous or intrathecal route.…”
Section: Gram-negative Bacillimentioning
confidence: 99%
“…13 Resistant organisms may require the use of aminoglycosides, polymyxin B, or colistin via intravenous or intrathecal route. 13,34,35 The use of intrathecal or intraventricular antibiotics is an important option to consider as even some of the most commonly used intravenous agents have poor blood-brain barrier penetrance.…”
Section: Gram-negative Bacillimentioning
confidence: 99%